Sanviva and Axcel: Platform Synergies and Value Creation Playbook
NA
The execution of private equity buy-and-build strategies within the highly fragmented European medical technology distribution sector has reached a new level of scale and complexity. On June 2nd 2026, Nordic private equity firm Axcel announced the simultaneous acquisition of four distinct regional distributors to establish Sanviva, a newly consolidated European medical device distribution network. By pulling Apodan (Denmark), PartnerMed (Norway), AllweCare Medical (Netherlands), and XboXLab (Sweden) into a unified platform, Axcel is building a single, pan-European gateway.
This consolidated platform, headquartered in Copenhagen, Denmark, establishes an immediate footprint across six European countries: Denmark, Sweden, Norway, Finland, Belgium and the Netherlands, operating with an initial workforce of approximately 60 employees.
The overarching strategy of the platform, under the leadership of newly appointed Group CEO Andreas von Scholten, is to act as a highly specialised local commercialisation partner for global medical device manufacturers and original equipment manufacturers (OEMs).
By providing direct access to multiple regional healthcare markets through a single partnership, Sanviva removes the need for OEMs to build out expensive, country-by-country sales forces or independently navigate local regulatory and public tendering frameworks.
Read the 'The Sanviva Case Study: Operational and Regulatory Dynamics of Axcel’s Pan-European MedTech Distribution Consolidation' report in full here..